GH1 and cancer: Also, long-term follow-up studies with the Israeli and Ecuadorian cohorts of individuals with Laron Syndrome (LS) (GH resistant due to dysfunctional mutations in GHR) remarkably find them to be completely resistant to all cancers (5, 6).